09:45 AM EDT, 10/30/2024 (MT Newswires) -- Avanos Medical ( AVNS ) reported Q3 adjusted earnings from continuing operations Wednesday of $0.36 per diluted share, up from $0.30 a year earlier.

Analysts polled by Capital IQ expected $0.35.

Net sales for the quarter ended Sept. 30 were $170.4 million, down from $171.3 million a year earlier.

Analysts surveyed by Capital IQ expected $175.3 million.

The company said it expects 2024 adjusted earnings of $1.30 and $1.35 per diluted share. Analysts surveyed by Capital IQ expect $1.39.

Revenue from continuing operations for the year is expected to be $683 million to $688 million, the company said. Analysts surveyed by Capital IQ expect $695.3 million.

Avanos shares were more than 8% lower in recent trading.

Price: 22.63, Change: +0.01, Percent Change: +0.04